vs

Side-by-side financial comparison of Commerce.com, Inc. (CMRC) and ORTHOPEDIATRICS CORP (KIDS). Click either name above to swap in a different company.

Commerce.com, Inc. is the larger business by last-quarter revenue ($89.5M vs $61.6M, roughly 1.5× ORTHOPEDIATRICS CORP). Commerce.com, Inc. runs the higher net margin — -9.3% vs -16.4%, a 7.1% gap on every dollar of revenue. On growth, ORTHOPEDIATRICS CORP posted the faster year-over-year revenue change (17.0% vs 2.9%). ORTHOPEDIATRICS CORP produced more free cash flow last quarter ($9.7M vs $-2.2M). Over the past eight quarters, ORTHOPEDIATRICS CORP's revenue compounded faster (17.4% CAGR vs 5.5%).

SPS Commerce, Inc. is a technology and application software company based in the United States that provides cloud-based supply chain management software. The company's headquarters are located in Minneapolis, Minnesota, but it also has a US office in New Jersey, and international locations in Amsterdam, Beijing, Breukelen, Hong Kong, Kyiv, Melbourne, Montpellier, Sydney, and Toronto.

OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.

CMRC vs KIDS — Head-to-Head

Bigger by revenue
CMRC
CMRC
1.5× larger
CMRC
$89.5M
$61.6M
KIDS
Growing faster (revenue YoY)
KIDS
KIDS
+14.1% gap
KIDS
17.0%
2.9%
CMRC
Higher net margin
CMRC
CMRC
7.1% more per $
CMRC
-9.3%
-16.4%
KIDS
More free cash flow
KIDS
KIDS
$11.9M more FCF
KIDS
$9.7M
$-2.2M
CMRC
Faster 2-yr revenue CAGR
KIDS
KIDS
Annualised
KIDS
17.4%
5.5%
CMRC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CMRC
CMRC
KIDS
KIDS
Revenue
$89.5M
$61.6M
Net Profit
$-8.4M
$-10.1M
Gross Margin
78.3%
73.2%
Operating Margin
-7.4%
-13.3%
Net Margin
-9.3%
-16.4%
Revenue YoY
2.9%
17.0%
Net Profit YoY
-250.0%
37.1%
EPS (diluted)
$-0.11
$-0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMRC
CMRC
KIDS
KIDS
Q4 25
$89.5M
$61.6M
Q3 25
$86.0M
$61.3M
Q2 25
$84.4M
$61.1M
Q1 25
$82.4M
$52.4M
Q4 24
$87.0M
$52.7M
Q3 24
$83.7M
$54.6M
Q2 24
$81.8M
$52.8M
Q1 24
$80.4M
$44.7M
Net Profit
CMRC
CMRC
KIDS
KIDS
Q4 25
$-8.4M
$-10.1M
Q3 25
$-2.2M
$-11.8M
Q2 25
$-8.4M
$-7.1M
Q1 25
$-353.0K
$-10.7M
Q4 24
$-2.4M
$-16.1M
Q3 24
$-7.0M
$-7.9M
Q2 24
$-11.3M
$-6.0M
Q1 24
$-6.4M
$-7.8M
Gross Margin
CMRC
CMRC
KIDS
KIDS
Q4 25
78.3%
73.2%
Q3 25
78.4%
73.9%
Q2 25
79.0%
72.1%
Q1 25
79.4%
73.0%
Q4 24
77.6%
67.5%
Q3 24
76.3%
73.4%
Q2 24
75.8%
77.3%
Q1 24
77.1%
72.0%
Operating Margin
CMRC
CMRC
KIDS
KIDS
Q4 25
-7.4%
-13.3%
Q3 25
-0.5%
-15.4%
Q2 25
-8.0%
-17.4%
Q1 25
-2.9%
-21.0%
Q4 24
-0.9%
-26.7%
Q3 24
-23.0%
-10.2%
Q2 24
-16.5%
-10.7%
Q1 24
-10.2%
-21.8%
Net Margin
CMRC
CMRC
KIDS
KIDS
Q4 25
-9.3%
-16.4%
Q3 25
-2.6%
-19.2%
Q2 25
-9.9%
-11.6%
Q1 25
-0.4%
-20.3%
Q4 24
-2.7%
-30.5%
Q3 24
-8.4%
-14.5%
Q2 24
-13.8%
-11.4%
Q1 24
-8.0%
-17.5%
EPS (diluted)
CMRC
CMRC
KIDS
KIDS
Q4 25
$-0.11
$-0.43
Q3 25
$-0.03
$-0.50
Q2 25
$-0.10
$-0.30
Q1 25
$0.00
$-0.46
Q4 24
$-0.03
$-0.70
Q3 24
$-0.09
$-0.34
Q2 24
$-0.15
$-0.26
Q1 24
$-0.08
$-0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMRC
CMRC
KIDS
KIDS
Cash + ST InvestmentsLiquidity on hand
$141.1M
$60.9M
Total DebtLower is stronger
$157.0M
$106.0M
Stockholders' EquityBook value
$39.4M
$346.6M
Total Assets
$308.8M
$508.6M
Debt / EquityLower = less leverage
3.99×
0.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMRC
CMRC
KIDS
KIDS
Q4 25
$141.1M
$60.9M
Q3 25
$142.0M
$57.7M
Q2 25
$134.5M
$70.1M
Q1 25
$120.7M
$58.8M
Q4 24
$178.2M
$68.8M
Q3 24
$168.4M
$76.1M
Q2 24
$275.8M
$28.9M
Q1 24
$265.2M
$47.7M
Total Debt
CMRC
CMRC
KIDS
KIDS
Q4 25
$157.0M
$106.0M
Q3 25
$157.3M
$105.3M
Q2 25
$157.5M
$102.7M
Q1 25
$157.8M
$77.4M
Q4 24
$216.5M
$77.5M
Q3 24
$76.9M
Q2 24
$340.9M
$11.2M
Q1 24
$340.5M
$11.3M
Stockholders' Equity
CMRC
CMRC
KIDS
KIDS
Q4 25
$39.4M
$346.6M
Q3 25
$42.8M
$349.3M
Q2 25
$38.8M
$355.5M
Q1 25
$38.1M
$347.1M
Q4 24
$33.4M
$354.6M
Q3 24
$29.0M
$370.9M
Q2 24
$26.1M
$371.3M
Q1 24
$26.9M
$370.6M
Total Assets
CMRC
CMRC
KIDS
KIDS
Q4 25
$308.8M
$508.6M
Q3 25
$309.5M
$493.5M
Q2 25
$302.5M
$503.6M
Q1 25
$286.3M
$470.3M
Q4 24
$340.3M
$473.2M
Q3 24
$335.1M
$489.3M
Q2 24
$452.5M
$430.8M
Q1 24
$442.5M
$437.2M
Debt / Equity
CMRC
CMRC
KIDS
KIDS
Q4 25
3.99×
0.31×
Q3 25
3.67×
0.30×
Q2 25
4.06×
0.29×
Q1 25
4.14×
0.22×
Q4 24
6.49×
0.22×
Q3 24
0.21×
Q2 24
13.06×
0.03×
Q1 24
12.65×
0.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMRC
CMRC
KIDS
KIDS
Operating Cash FlowLast quarter
$980.0K
$10.3M
Free Cash FlowOCF − Capex
$-2.2M
$9.7M
FCF MarginFCF / Revenue
-2.4%
15.8%
Capex IntensityCapex / Revenue
3.5%
1.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$16.9M
$-16.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMRC
CMRC
KIDS
KIDS
Q4 25
$980.0K
$10.3M
Q3 25
$10.6M
$-581.0K
Q2 25
$13.6M
$-10.5M
Q1 25
$401.0K
$-4.2M
Q4 24
$12.4M
$-4.0M
Q3 24
$5.6M
$-10.3M
Q2 24
$11.7M
$-6.1M
Q1 24
$-3.4M
$-6.7M
Free Cash Flow
CMRC
CMRC
KIDS
KIDS
Q4 25
$-2.2M
$9.7M
Q3 25
$7.6M
$-3.4M
Q2 25
$11.9M
$-13.9M
Q1 25
$-424.0K
$-8.4M
Q4 24
$11.6M
$-4.2M
Q3 24
$4.5M
$-11.7M
Q2 24
$10.7M
$-12.8M
Q1 24
$-4.2M
$-13.2M
FCF Margin
CMRC
CMRC
KIDS
KIDS
Q4 25
-2.4%
15.8%
Q3 25
8.8%
-5.6%
Q2 25
14.1%
-22.8%
Q1 25
-0.5%
-16.0%
Q4 24
13.3%
-8.1%
Q3 24
5.4%
-21.4%
Q2 24
13.0%
-24.2%
Q1 24
-5.3%
-29.4%
Capex Intensity
CMRC
CMRC
KIDS
KIDS
Q4 25
3.5%
1.0%
Q3 25
3.4%
4.6%
Q2 25
2.0%
5.6%
Q1 25
1.0%
8.1%
Q4 24
0.9%
0.5%
Q3 24
1.3%
2.5%
Q2 24
1.3%
12.7%
Q1 24
1.0%
14.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMRC
CMRC

Subscription And Circulation$65.2M73%
Partner And Services$24.4M27%

KIDS
KIDS

Segment breakdown not available.

Related Comparisons